StonvexLoading…
StonvexStonvexStonvexCore line items from WES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.84B | $3.60B | $3.11B | $3.25B |
Operating Income | $1.60B | $1.97B | $1.38B | $1.59B |
Net Income | $1.18B | $1.57B | $1.02B | $1.22B |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $15.00B | $13.14B | $12.47B | $11.27B |
Total Liabilities | $10.84B | $9.77B | $9.44B | $8.16B |
Cash & Equivalents | $819.49M | $1.09B | $272.79M | $286.66M |
Free Cash Flow OCF − CapEx | $1.49B | $1.30B | $926.25M | $1.21B |
Shares Outstanding | Not available | Not available | Not available | Not available |